左心室质量指数和相对壁厚预测心房高频发作在心脏起器植入患者
Qin Zhang1, Limin Xiang2, Gege Zhao3
1Department of Cardiology, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, China.
Echocardiography (Mount Kisco, N.Y.)
|December 10, 2025
概括
在心脏器件植入后,心房高频发作 (AHREs) 通过心声回声指数预测. 左心室质量指数 (LVMI) 和相对壁厚 (RWT) 是AHREs的独立预测指标,指导早期干预.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 心声回声扫描 (Echocardiography) 是一种心声回声扫描.
背景情况:
- 在心脏植入式电子设备 (CIED) 植入后,心房高频发作 (AHREs) 与中风风险有关.
- 左心室质量指数 (LVMI) 和相对壁厚 (RWT) 等心声指数可以预测AHREs.
研究的目的:
- 研究CIED植入后AHREs的LVMI和RWT的预测价值.
- 在接受心脏起器的患者中确定AHREs的心声学预测因子.
主要方法:
- 对122名接受双室心脏起器植入的患者进行了回顾性单中心研究.
- 分析临床数据,血清学标志物和心声回声指数.
- 考克斯回归和ROC曲线分析以确定AHREs的LVMI和RWT的预测指标和预测值.
主要成果:
- 较低的RWT和较高的LVMI独立地与AHRE风险增加有关.
- ROC分析表明LVMI (AUC=0.722) 和RWT (AUC=0.716) 的预测值.
- 患有LVMI≥114.930或RWT<0.392的患者显示AHRE的发病率较高.
结论:
- 在心脏起器植入后,LVMI和RWT是AHREs的独立预测因素.
- 特定的LVMI (≥114.930) 和RWT (<0.392) 值可以识别高风险患者.
- 这些发现支持早期临床干预,对患有高风险的病人AHREs.
相关概念视频
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
194
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
194
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
362
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
362
01:22Mitral Valve Prolapse II: Assessment and Management
380
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
380
01:20Mitral Regurgitation I: Introduction
371
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
371
01:22Mitral Stenosis I: Introduction
386
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
386